Bioprogress Switzerland

Who We Are

An executive search and talent acquisition specialist with a wealth of experience in the life science business sector
An alternative to the generalist search firms that offer only general search services
Able to find the right talent for you with the right approach and understanding the complexity of the life science industry
Able to build pools helping our clients to attract a long term and sustainable talent pipeline for current and future requirements, placing your company ahead of competition
Company Size (Fulltime employees)
Year of foundation
1997
Headquartner in China
Plan in China
We have an office in HK,Shanghai and BKK
Jacob Hoekstra
CEO 
Functionality
Sam Meredith
Vice President 
Functionality

FJS Biopharmaceutical Inc. United States

At FJS Biopharmaceutical Inc., we combine technological innovation with world class process excellence. These enable our customers to deliver their discoveries. In our extensive contract development services portfolio we use advanced technologies to quickly and efficiently deliver products such as monoclonal antibodies, complex proteins and recombinant proteins.

Changes in the global marketplace are quickly altering the demands on biopharmaceutical manufacturing facilities. we have changed to Continuous Manufacturing Processes design that is cost-effective, flexible and responsive to a diversified product line. Continuous manufacturing processes offers a number of advantages:
1. More agile and flexible, and can therefore respond more rapidly to changes in supply or demand.
2. Reducing or eliminating scale-up bottlenecks could also help to accelerate the path to market for breakthrough
pharmaceuticals.
3. More efficient, reliable and cost-effective than traditional batch methods, resulting in significant cost savings down the line.
4. Producing smaller environmental footprint and reduce the risk of product quality failures compared to batch systems.
5. Supports a systematic, scientific and risk-based approach to pharmaceutical development. Development of a robust
process relies on utilizing the acquired product and process understanding to identify sources of variation to product quality
and to design appropriate control strategies to address these risk areas.
6. provides an opportunity to utilize this enhanced product and process understanding to adopt advanced manufacturing
controls and to produce uniformly high-quality products with reduced waste resulting from the generation of out-of-
specification material.

We are a preferred global partner to the Biopharmaceutical, biotech and specialty ingredients markets. Our solutions improve life quality by preventing illness, enabling healthier lifestyles and supporting a safe environment.
Company Size (Fulltime employees)
Year of foundation
2009
Funding Status
Round B financing
Headquartner in China
Jessica Li
CEO 
Functionality

IHM-GBA China

Based in Guanghzou, China, IHM-GBA is an innovation center focusing on high performance medical device. We are seeking global opportunities of bringing disruptive technologies to the Chinese market. We invest in and partner with startups that are interested in exploring China and use our resources to commercialize their products.

Website:
www.ihm-gba.com
Year of foundation
2019
Please specify your partnering goal
investment/partnership/license
Headquartner in China
Investment Focus
Medical device
Mr shu zeng
Director 
Functionality

Iono Pharma LLC United States

We are a pharmaceutical startup in Memphis, Tennessee. Our focus is on pediatric drug delivery designs as we transform FDA approved therapeutic compounds into pediatric friendly drug delivery systems. We have designed several Epinephrine prodrugs to eliminate the need to use Epipen injections. We seek seed funding for organic synthesis, formulation development and CMC drug development.
Funding Status
Seed funding
Headquartner in China
Plan in China
We filed a patent in china (still pending). We are looking for investors to develop our drug delivery in China.
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Slides Deck
(pdf, 813.74KB)
Dr Hassan Almoazen
Dr Hassan Almoazen
Founder and CEO 
Functionality

Nodes Advisors AG Switzerland

We are a corporate finance firm committed to advancing the field of Healthcare through advisory,and investments.

We advise and buy-side and sell side corporates and Family offices on investment in Healthcare & life Sciences across Switzerland, Europe and the US.
Company Size (Fulltime employees)
Year of foundation
2018
Headquartner in China
Plan in China
We would like to partner with strong Chinese funds who are interested in incubating and investing in European and US early stage companies and facilitate market acess and technology integration in chinese market.
Eliott Harfouche
Partner 
Functionality

PhysioCue United States

PhysioCue is digital health and therapy device development company, located in the heart of Silicon Valley, California. PhysioCue has developed the thermal neurostimulation technology for a non-invasive hypertension therapy device and a migraine and headache therapy device and migraine and headache pain monitoring mobile app. Using our device once daily for 5-minute treatments gradually elongated the reduced blood pressure. PhysioCue's therapy devices are efficient, safe, easy to use, and has none of the side effects associated with drugs. We have manufactured our devices and delivered devices to our potential partners and users. We've received positive feedback from many people who have tried and liked our devices. PhysioCue devices can help people and save lives.
Company Size (Fulltime employees)
Year of foundation
2013
Funding Status
PhysioCue is seeking to raise $7M for a syndicate in our Series A round of financing.
Headquartner in China
Plan in China
Set up a JV in China and looking for a distribution partner.
Simon Yi
LinkedIn logo President 
Functionality

Simcere Pharmaceutical Group China

We are rapidly transitioning to an innovation and R&D driven Pharmaceutical company, leveraging our leading manufacturing and commercial capabilities to achieve our mission of “providing today' s patients with medicines of the future“ We have been continuously recognized as one of the “Top 10 Innovative Pharmaceutical Enterprises in China” 1 and “Top 100 Pharmaceutical Manufacturing Enterprises of China”

Wayne Yin
BD Director 
Functionality